This article discusses the use of inhaled insulin rather than injectable insulin for the treatment of diabetes mellitus. Studies have indicated that patien... McMahon,Graham,T.,... - 《New England Journal of Medicine》 被引量: 161发表: 2007年 Drug Delivery Systems for the Treatment of Diabete...
The treatment of diabetes requires a multidisciplinary approach. Pharmacists are highly accessible and well trained to provide medication management services for patients with diabetes. It is therefore important for pharmacists to keep up to date with new advancements in diabetes care, including ...
While it is true that there is currently no permanent relief from multiple sclerosis, there are, however, varieties of treatments and therapies that go beyond conventional medicine. In this article, we would look at the treatment options as well as complementary and alternative treatments that are...
The main medicine people with Type 1 diabetes take on a daily basis is insulin, but did you know that other non-diabetes-related medications can affect your blood sugar, too? This side effect can create havoc on your glucose management if you don’t adjust your insulin levels to accommodate...
We further restricted our cohort to non-diabetic, obese men by excluding men with a prior diabetes mellitus diagnosis, a hemoglobin A1c > 6.5%, or having ever received insulin or metformin. Men were then stratified into cohorts of those that did and did not receive a semaglutide ...
A Dual-Microparticle System Prevents and Reverses Type 1 Diabetes in Non-Obese Diabetic Mice Conclusions: An injectable dual-MP system demonstrates promise for T1D through reversal of overt hyperglycemia in a preclinical mouse model of autoimmune d... Joshua Stewart,Jamal Lewis,Chang Qing Xia,......
day methylprednisolone for three consecutive days is recommended [56]. Although some adverse effects may be reversible or controllable, systemic corticosteroid treatment may be related to a risk of side effects, including adrenal suppression, osteoporosis, cushingoid changes and diabetes mellitus [55,57...
US National Library of Medicine. ClinicalTrials.gov https://clinicaltrials.gov/ct2/show/NCT03222973 (2022). Stangel, M., Kuhlmann, T., Matthews, P. M. & Kilpatrick, T. J. Achievements and obstacles of remyelinating therapies in multiple sclerosis. Nat. Rev. Neurol. 13, 742–754 (2017...
US National Library of Medicine. ClinicalTrials.gov https://clinicaltrials.gov/ct2/show/NCT03222973 (2022). Stangel, M., Kuhlmann, T., Matthews, P. M. & Kilpatrick, T. J. Achievements and obstacles of remyelinating therapies in multiple sclerosis. Nat. Rev. Neurol. 13, 742–754 (2017...
Medicine and Allergology, Department of Medicine, School of Medicine, Showa University, Tokyo, Japan; 2Medical, AstraZeneca K.K., Tokyo, Japan; 3Medical, AstraZeneca K.K., Osaka, Japan Correspondence: Akihiko Tanaka, Division of Respiratory Medicine and Allergology, Department of Medicine, School...